EASME

EASME is a European Union executive agency that supports small and medium-sized enterprises and promotes innovation in Europe. It manages projects in the areas of small and medium-sized enterprises, as well as the environment, energy, and maritime sectors, funded by COSME, LIFE, and EMFF. EASME organizes the European Sustainable Energy Week and serves industries such as environmental management, energy production, and maritime activities.

Past deals in Nordic Europe

Breivoll Inspection Technologies

Grant in 2019
Breivoll Inspection Technologies (BIT) is a Norway-based company specializing in the assessment and maintenance of metallic water infrastructure. It provides innovative inspection services that aid utilities in evaluating the condition of their water pipelines and adopting proactive management strategies. Utilizing state-of-the-art Acoustic Resonance Technology, BIT performs in-line inspections of metallic water and district heating pipes. The company's advanced PipeScanner, which is lightweight and equipped with dual cameras, delivers precise measurements of internal and external corrosion, pipeline thickness, and leak detection while identifying obstacles within the pipes. BIT is recognized as a leading international provider in this specialized field, contributing significantly to the longevity and reliability of critical water infrastructure.

Polymer Factory

Grant in 2019
Polymer Factory, established in 2006 at the Royal Institute of Technology in Stockholm, Sweden, is a prominent supplier of advanced dendritic and polymeric materials, also offering contract research services. Its product range includes monodisperse dendritic polymers derived from 2,2-bis(methylol)propionic acid, such as biocompatible bis-MPA dendrimers and dendrons. The company specializes in the synthesis of high-quality macromolecules, custom materials, and calibrants for MALDI-ToF. Polymer Factory holds exclusive rights to several advanced materials and provides global access to polyester (Boltorn™) and polyester amide (Hybrane®) hyperbranched polymers for research purposes.

Hefring Marine

Grant in 2019
Hefring Marine is an Icelandic deep-tech startup based in Reykjavík that specializes in providing advanced marine solutions through its Intelligent Marine Assistance System (IMAS). This innovative hardware-enabled software-as-a-service (SaaS) platform utilizes artificial intelligence, machine learning, and the Internet of Things to deliver real-time navigation guidance for both manned and unmanned vessels. By leveraging data-driven insights, Hefring Marine's system helps operators enhance safety, reduce fuel consumption by up to 25%, and significantly lower carbon emissions. Additionally, it mitigates the risks associated with wave slamming, potentially reducing impacts by up to 70%, thereby ensuring a safer and more comfortable experience for crew and passengers. The continuous learning capability of the AI improves operational guidance over time, addressing issues of inexperience and enhancing situational awareness among operators.

Microbium

Grant in 2019
Microbium is an innovative research and development company specializing in microbiological detection protocols tailored for specific industrial applications. Founded to address the pressing challenges posed by microbial contamination, Microbium collaborates closely with national laboratories and analytical organizations in Russia, Denmark, and Slovenia. The company develops advanced electronic devices that automate the detection and counting of harmful microorganisms, such as E. coli and coliforms, in drinking water and various industrial products. Additionally, Microbium employs a bioremediation process to effectively eliminate these microorganisms from water supply systems and production lines, thereby helping clients reduce contamination hotspots, lower production costs, and minimize their environmental impact.

EpiGuard

Grant in 2019
EpiGuard is a Norwegian company founded in 2015 by a group of doctors from Oslo University Hospital, in collaboration with Inven2, Eker Group, and Hansen Protection. The company specializes in the development and manufacturing of medical transportation systems designed to facilitate the safe transfer of patients with contagious diseases. EpiGuard's flagship product is a single-patient isolation and transport system that effectively prevents the spread of infection from infected patients and safeguards them from contaminated environments. This innovative solution not only protects medical staff but also ensures that patients receive appropriate treatment during transportation. With a strong foundation in various medical fields, including intensive care and infectious diseases, EpiGuard leverages its expertise to enhance patient safety and care in challenging medical scenarios.

Joma International AS

Grant in 2019
Joma International AS is a nanotechnology company located in Bergen, Norway. They specialise in titania nanoparticles and photocatalysis. Joma was founded in 2005 with a plan to mine and utilize various metals from the mountain Joma in mid-Norway. The focus later turned towards titania and how to make nanoparticles from this material. During a thorough development phase they created a unique nanoparticle with a patented and scalable production process. Joma is an R&D driven company and they are actively exploring new areas of use for their particle. In 2014, they built up an in-house lab for analysis and development, which allows us to formulate products with their tiny particles as the key component. The development work is driven by close collaborations with their customers, to find the best suited products for their needs. They have high standards when it comes to quality and performance, and are committed to their customers. They make surface treatment products for many different surfaces, because they do not believe that one single product can serve all applications. Their products which are tailor-made for concrete are now ready to hit the market – to make the world a cleaner place.

ProtectPipe

Grant in 2019
ProtectPipe is a Finnish microbiotechnology company producing an innovative microbe solution that removes organic waste from drainpipes. The microbe solution moves to the areas with build-up in the pipes and devours the waste. That is an ecological way to stop the erosion in pipes and prevent any harmful waste from entering the fragile environment.

Modvion

Grant in 2019
Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Minnemera

Grant in 2019
Minnemera, established in 2017 and based in Stockholm, Sweden, specializes in developing digital cognitive screening tools. These tools automatically compare an individual's test results with normative data and their own baseline values to detect abnormalities, aiding in early detection of neurological conditions.

ImmuneBiotech

Grant in 2019
ImmuneBiotech AB, established in Lund, Sweden in 2013, specializes in the research and development of novel microbiome therapeutics. The company focuses on probiotic lactic acid bacteria and synbiotic formulations that target the gut microbiota and the immune system, aiming to prevent and treat autoimmune and chronic inflammatory conditions such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes.

Raytelligence

Grant in 2019
Raytelligence AB is a Swedish company focused on developing advanced microwave sensors for the healthcare and industrial markets. Founded in 2015 as a subsidiary of Swedish Adrenaline, Raytelligence specializes in solutions that monitor vital signs such as heartbeat, movement, and body position. The company's flagship product, the RayVS1 sensor, is designed for home use and features capabilities for signal processing and analysis through a cloud service. In addition to its healthcare applications, Raytelligence has expanded into the industrial sector, securing clients in road construction and partnering with a major Swedish IT provider in the e-Health market. The team's expertise spans industrial design and radar signal processing, positioning Raytelligence as a key player in the development of innovative sensor technology.

Trackwell

Grant in 2019
Trackwell Ltd, established in 1996 in Iceland, specializes in developing wireless communication solutions and is recognized for its expertise in mission-critical systems for telecom operators and government agencies. The company offers Mobile Resource Management (MRM) solutions as a software as a service (SaaS), equipping enterprises with tools to effectively manage their resources, including employees, vehicles, vessels, and other mobile assets. Trackwell's comprehensive suite of software includes fleet tracking, field workforce management, and specialized systems for fishing companies, enabling clients to gain real-time visibility into their operations. With hundreds of companies utilizing Trackwell MRM systems to oversee thousands of employees and a significant number of vehicles across various domains, the company has established itself as a leading provider in the resource management sector.

Brain Stimulation

Grant in 2019
Founded in Sweden in 2011, Brain Stimulation specializes in innovative neurological rehabilitation. They leverage brain plasticity research to develop effective, individualized care for stroke, dementia, traumatic brain injuries, and other degenerative brain diseases.

PlatoScience Medical

Grant in 2019
PlatoScience ApS is a Copenhagen-based company founded in 2015 that specializes in neurostimulation technology. It manufactures the PlatoWork headset, a plug-and-play device designed for transcranial direct current stimulation (tDCS). This non-invasive technology modulates neuronal activity by applying a low-intensity current to the scalp, allowing users to enter specific mindsets conducive to task completion. The company aims to make neurostimulation accessible and easy to use for everyone, facilitating improved mental health and enhanced cognitive performance. By providing a wearable device that sends small electronic signals to the brain, PlatoScience seeks to support users in achieving deep focus and effectively performing various tasks.

Svarmi

Grant in 2019
Svarmi is an Icelandic company that develops unmanned aerial vehicles for aerial photography, mapping, and specialized tasks, and also provides a nature data management platform that helps organizations build digital infrastructure for biodiversity assessment. The platform offers a data analytics pipeline that establishes consistent metrics aligned with nature-related financial disclosure frameworks, enabling rapid evaluation of infrastructure projects and bottom‑up reporting of nature impact for geologists and other stakeholders.

Scandion Oncology

Grant in 2019
Scandion Oncology A/S is a biotechnology company based in Copenhagen, Denmark, focused on developing innovative treatments for chemotherapy resistance in cancer patients. Founded in 2017, the company is advancing several drug candidates, including SCO-101, which is currently undergoing Phase II clinical trials for breast and colorectal cancers, and SCO-201, which is in late pre-clinical development for solid tumors. Scandion Oncology aims to improve the outcomes and quality of life for cancer patients facing the challenge of drug resistance, a significant obstacle in oncology that affects approximately half of all patients undergoing chemotherapy. The company has established collaboration agreements with the University of Copenhagen to co-develop SCO-301, a candidate designed to counteract drug resistance, and is also exploring the potential of combining SCO-101 with Alligators mitazalimab to enhance anti-tumor effects in resistant tumor models.

Pila Pharma

Grant in 2019
Pila Pharma AB is a clinical stage biotech company based in Malmö, Sweden, focused on developing XEN-D0501, a potent and selective TRPV1 antagonist. This innovative compound is being investigated as a treatment for type 2 diabetes, obesity, and the rare painful condition known as erythromelalgia. XEN-D0501 has undergone testing in over 300 subjects during phase 1 and phase 2 trials, demonstrating a favorable safety profile in healthy volunteers and patients with various conditions, including overactive bladder disease and chronic cough. The compound has shown efficacy in improving glucose-stimulated insulin secretion in type 2 diabetics. Recent preclinical studies have completed successfully without any registered side effects, allowing XEN-D0501 to advance to longer clinical trials. In July 2022, Pila Pharma received US Orphan Drug Designation for this compound in the context of erythromelalgia.

Gedea Biotech

Grant in 2019
Gedea Biotech develops an antibiotic-free treatment for vaginal fungal infections using its substance GA101. This natural substance lowers pH, provides physical barrier protection, and inhibits biofilm formation. The company's first product is a topical treatment for vaginal fungal infections.

OnDosis

Grant in 2019
OnDosis is a Swedish company founded in 2017, focusing on personalized medicine through its innovative dosing technology. The company specializes in delivering flexible and individualized dosing of oral medications, which are formulated as micro units like pellets, granules, mini tablets, or powders. By integrating digital technologies with traditional drug-based treatments, OnDosis aims to enhance disease management and improve patient adherence, particularly for conditions such as ADHD, pain management, and immunosuppression in organ transplant recipients. Their approach addresses the limitations of conventional tablets or capsules, providing greater convenience and improved health outcomes for patients. The technology developed by OnDosis is rooted in research from AstraZeneca and is supported by a network of strategic partners that assist in various core functions, including formulation, device development, and regulatory compliance.

Nornir

Grant in 2019
Nornir is a Norwegian smart city operator specializing in network automation. It offers an end-to-end software infrastructure and wireless coverage for smart cities, integrating AI services and empowering IoT with collective intelligence.

ChemoTech

Grant in 2019
Scandinavian ChemoTech AB is a clinical development company headquartered in Lund, Sweden. It specializes in cancer care and pain management solutions, primarily through its innovative product, IQWave. This electroporation device uses short electric pulses in conjunction with localized or intravenous chemotherapy to treat various cancers, including head and neck squamous cell carcinoma, malignant melanoma, and breast adenocarcinoma, among others. The company's founders bring extensive experience in surgical oncology and clinical research, driving its commitment to advancing cancer treatment through genuine research and clinical trials. ChemoTech markets its products via distribution channels and a network of opinion leaders across regions such as South East Asia, India, and the Philippines. Established in 2013, the company continues to focus on developing effective therapies for cancer patients.

Black Bruin

Grant in 2019
Black Bruin Inc. is one of the world’s leading suppliers of LSHT radial piston-cam lobe hydraulic motors and rotators. Their trade mark Black Bruin offers a high quality solution for agriculture, construction and mining, road building and forestry equipment applications. As an international operator located in Jyväskylä, Central Finland, we employ nearly 100 fully trained professionals and have a distribution network which covers over 25 countries.

Capitainer

Grant in 2019
Capitainer is a Swedish medical device company that develops volumetric blood collection devices for fixed-volume dried blood spots collected at home. The device enables patients to remotely collect a predefined blood volume, which can be mailed to a laboratory for analysis. The technology aims to reduce patient travel and healthcare resources required for blood sampling, while delivering improved accuracy over conventional methods and offering cost and environmental savings for healthcare providers handling large volumes of samples. Founded in 2016 and based in Stockholm, Capitainer focuses on enabling convenient, safe, and reliable remote blood collection for quantitative testing.

Eco Wave Power

Grant in 2019
Eco Wave Power is a Sweden-based company specializing in wave energy technology. It is the sole inventor, owner, and developer of the EWP wave energy converters, which are designed to convert ocean and sea waves into clean electricity. The company's innovative technology utilizes point absorber floating devices, known as floaters, that can be installed on existing marine structures like piers and breakwaters or in locations where such structures are needed. Eco Wave Power's approach is aimed at providing a smart and cost-efficient solution for energy harvesting from waves. The company has been recognized for its advancements in the field, having received the Frost & Sullivan Product Innovation Award, marking a significant achievement in the wave energy sector. With projects in places such as Gibraltar and Israel, Eco Wave Power is positioned to become a leader in renewable energy generation through wave power.

Goava

Grant in 2019
Founded in late 2016 by Jonas Ehne, Henrik Stridsberg, Carl Hall, and Johan Rogebrant, Goava develops a sales intelligence platform. This platform uses big data and machine learning to provide accurate, actionable insights for sales teams, enabling efficient lead tracking.

Samplix

Grant in 2019
Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

SagaNatura

Grant in 2019
SagaNatura is an Icelandic biotech company that specializes in the development, production, and export of health products derived from premium Icelandic ingredients. The company focuses on the organic herb Archangelica Angelica and high-quality Astaxanthin, offering a range of consumer products that are safe, vegan-friendly, and of Icelandic origin. SagaNatura operates under two primary brands, SagaMedica, established in 2000, and KeyNatura, launched in 2014. The company aims to promote healthier lifestyles through its clean-label nutrition products, which address various health issues, including vision, skin health, energy, and concentration. By leveraging Iceland's pristine environment, SagaNatura is committed to providing high-quality health solutions that contribute to the well-being of consumers.

Seaweed Solutions

Grant in 2019
Seaweed Solutions AS is a prominent seaweed cultivation and business development company established in 2009, focusing on large-scale ocean farming for diverse applications including food, feed, pharmaceuticals, and biomaterials. With a comprehensive control over the entire value chain, the company operates proprietary seed hatcheries, employs innovative deployment methods, and maintains processing plants. Seaweed Solutions is at the forefront of modern seaweed farming, utilizing its patented cultivation technology, the Seaweed Carrier, which is based on decades of accumulated expertise. The company operates the largest seaweed farms in Europe, primarily dedicated to brown macroalgae, and is staffed by a specialized international team versed in biology, marine engineering, biotechnology, and business. Seaweed Solutions aims to become the leading European supplier of cultivated biological seaweed and seaweed seeds while developing partnerships and providing turnkey solutions within cultivation technology, raw material sourcing, market development, and environmental services.

Pre Diagnostics

Grant in 2019
Pre Diagnostics is a Norwegian biomarker diagnostics company focused on the early detection of neurodegenerative diseases, especially Alzheimer’s disease. It develops blood-based in vitro diagnostic tests that capture disease-specific systemic responses, including intracellular analysis of monocytes to assess beta-amyloid clearance, with the aim of identifying disease onset before symptoms, improving patient stratification, and supporting precision medicine through laboratory services that back the diagnostic workflow.

BoMill

Grant in 2019
BoMill AB, founded in 2001 by biochemist Bo Löfqvist, specializes in grain quality sorting solutions, particularly for wheat, durum wheat, barley, and oats. The company offers products like TriQ, a process capacity grain sorting solution, and IQ, designed for laboratory use. BoMill's expertise lies in single kernel sorting technology, which enhances the analysis and separation of grain and granular products in the food industry. The company supports various sectors, including seed cleaning, organic farming, and milling industries, by providing essential services such as customer care, remote access, and installation assistance. Headquartered in Malmö, Sweden, BoMill distributes its technology and knowledge across Europe, North America, and Australia through a combination of direct sales and partnerships with agents and distributors.

Attavik

Grant in 2019
Attavik A/S is an innovative technology company originally founded in Greenland and now based in Denmark. The company addresses the challenges of mobile phone and internet connectivity in rural areas where traditional service is limited or nonexistent. Attavik offers a unique solution that leverages a peer-to-peer mesh network, allowing personal devices to connect over distances of up to 8 kilometers using Super Wi-Fi technology. This enables affordable and reliable mobile and internet connections, facilitating communication through text messages, voice calls, data sharing, and video streaming. The Attavik app enhances user connectivity without the reliance on centralized servers, making it particularly valuable in regions lacking mobile coverage. The technology is protected by U.S. patents, highlighting its innovative approach to improving communication access in underserved areas.

Elypta

Grant in 2019
Elypta develops a liquid biopsy platform using metabolism-based biomarkers and artificial intelligence. Its platform measures glycosaminoglycan metabolites in blood and urine, aiming to enable earlier detection and monitoring of various cancer types.

BioMensio

Grant in 2019
BioMensio develops smart handheld devices for rapid, on-site detection of multiple biological targets. Its core technology enables label-free assays and facilitates development of new bio-screening applications. The company's products include BioMensio devices and a novel miniaturized microarray platform, serving point-of-care, food safety, and bio-security applications.

Greenbird Integration Technology

Grant in 2019
Greenbird Integration Technology AS is a software and solutions firm based in Oslo, Norway, with additional offices in Stavanger and Palo Alto. Founded in 2009, the company specializes in providing IT advisory services and integration solutions tailored for both public and private organizations across Europe. Its flagship product, Utilihive, serves as a domain-specific integration platform as a service (iPaaS) designed to support utilities in their digital transformation efforts. Utilihive empowers sectors such as smart metering, smart grid, smart cities, and the industrial Internet of Things, facilitating efficient data integration and operational processes. The company also offers consulting services that include strategic advisory, enterprise architecture, and solution design and development. Greenbird's technology is actively utilized by utilities serving over 65 million clients in various regions, including Scandinavia, Germany, the UK, the Middle East, and the Far East. In August 2023, Greenbird was acquired by GE Vernova and integrated into the Grid Software Business, enhancing its role in the ongoing energy revolution.

EmeraMed

Grant in 2019
EmeraMed Limited is a privately held biotechnology company based in the Republic of Ireland, with operations in Ireland, Sweden, and the United States. The company's ownership group consists mainly of physicians, dentists, and patients who have previously used its products as dietary supplements. EmeraMed is focused on developing a lipophilic antioxidant capable of penetrating the blood-brain barrier. The company's primary goal is to chelate free iron and various heavy metals, including mercury and lead, which can generate harmful free radicals. By addressing these issues, EmeraMed aims to help healthcare providers restore normal mitochondrial function and enhance overall health.

Elliptic Labs

Grant in 2019
Elliptic Labs is a Norwegian technology company specializing in AI-driven virtual smart sensors for smartphones, laptops, IoT devices, and automotive industries. Its proprietary ultrasound and machine learning algorithms enable touch-free gestures, presence sensing, and wellness detection without the need for dedicated hardware sensors.

Vulcur Medtech

Grant in 2019
Vulcur Medtech is a medical device development company based in Vanløse, Denmark, established in 2018. The company specializes in wound healing through its innovative VulCur MedTech laser technology. This device is designed to target and eliminate biofilm-producing bacteria in chronic wounds by using laser pulses that penetrate tissue, effectively ablating bacteria while preserving human cells. By facilitating the healing of otherwise untreatable wounds, Vulcur Medtech's approach not only accelerates the healing process but also enhances patients' quality of life.

Mussila

Grant in 2019
Mussila is an Icelandic EdTech company specializing in creative digital learning solutions for children. Its unique Learn, Play, Create methodology engages young learners through award-winning apps focused on music education.

AFYX Therapeutics

Grant in 2019
AFYX Therapeutics A/S is a pharmaceutical company based in Copenhagen, Denmark, focused on developing and manufacturing treatments for mucosal diseases. Established in 2014, the company is known for its flagship product, the Rivelin® patch, which is designed for the treatment of oral lichen planus. This innovative patch is flexible, biodegradable, and adheres to mucosal surfaces, utilizing electrospinning technology to deliver medication directly to the affected area. By offering targeted therapies for conditions that currently lack approved treatment options, AFYX Therapeutics aims to enhance patient relief and support recovery without disrupting daily activities.

Ekowasher

Grant in 2018
Ekowasher is a Stockholm-based company that designs and manufactures environmentally optimized washing systems with a focus on low water consumption and minimal environmental impact. Established in 2015, Ekowasher launched its first product, Hullwasher, which is specifically designed for cleaning the bottoms of boats. In 2018, the company expanded its product line with the introduction of Graffiti blades, which are used for effective surface cleaning against graffiti. Through its innovative solutions, Ekowasher aims to provide eco-friendly alternatives for various cleaning applications.

Comptek Solutions

Grant in 2018
Comptek Solutions is a Finnish developer specializing in advanced surface engineering for compound semiconductors. Its Kontrox quantum surface engineering process creates defect-free, crystalline surfaces on III-V materials, enabling higher-quality semiconductor devices used in CMOS manufacturing, radio frequency components, optoelectronics, power electronics, and concentrated photovoltaics. Founded in 2017 and based in Turku, the company also offers passivation technologies that mitigate aggressive oxidation, reducing atomic-level defects and improving device efficiency, reliability and manufacturability. Kontrox has demonstrated substantial performance gains in devices such as microLEDs, and the company provides customized services to fit diverse substrate and fabrication flows, helping clients produce more efficient, reliable, and affordable devices across optoelectronics, RF and power electronics markets.

Gleechi

Grant in 2018
Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

Klaria Pharma Holding

Grant in 2018
Klaria Pharma Holding is a Swedish pharmaceutical company focused on rapid-acting products. It combines patented film-based technology that attaches to the oral mucosa with proven pharmaceuticals to form a drug delivery platform. The platform uses an alginate-based polymer film to enable absorption of an active substance through the oral mucosa, offering rapid onset and potential for diverse therapeutic applications.

RoboFit ApS

Grant in 2018
RoboFit ApS is a Danish company located in Christiansfeld that specializes in the development and marketing of a rehabilitation robot designed for individuals with limited muscle strength. This innovative technology facilitates effective shoulder rehabilitation by enabling patients to exercise through the full range of motion. The company's focus is on providing measurable and motivational support during rehabilitation sessions, enhancing the overall recovery experience for patients with shoulder injuries or conditions.

Moonwalk Innovation

Grant in 2018
Moonwalk turns Epic Challenges into Stellar Startups to improve 1 Billion Lives from its venture studios in London and Oslo. Moonwalk revolutionized venture creation with its award-winning system of innovation, entrepreneurship and investing. It made 3 portfolios of 18 startups now growing on 3 continents in 3 years. It engaged 150 innovators backed by 300 angel investors. Moonwalk made 5 companies for a Norwegian post-oil economy; democratizes health with 8 startups in seed stage; and reinvents education with 5 startups in seed stage.

NewBanking ApS

Grant in 2018
Founded in 2015, NewBanking operates a user identity platform that enables secure and convenient cross-business identity verification for end-users. It empowers users with control over their data and online identities.

IRLAB Therapeutics

Grant in 2018
IRLAB Therapeutics AB is a Swedish research and development company focused on creating innovative drug treatments for neurological disorders, particularly Parkinson's disease. The company has developed several clinical candidates, including Mesdopetam, a dopamine D3 receptor antagonist that has completed Phase IIa trials for dyskinesia, and IRL752, which has also progressed through Phase IIa trials for postural dysfunction. In addition to these, IRLAB is advancing other research initiatives aimed at addressing neurodegenerative conditions and the effects of aging. These include programs designed to develop alternatives to levodopa, a common Parkinson's treatment, and additional compounds targeting various dysfunctions associated with Parkinson's disease. Based in Gothenburg, Sweden, IRLAB is committed to enhancing the quality of life for patients suffering from neurological and psychiatric illnesses through its innovative therapeutic approaches.

AcouSort

Grant in 2018
AcouSort develops and sells laboratory equipment and integrated solutions using ultrasound to separate, wash, and enrich cells, exosomes, and other biological particles for research and diagnostics.

720 Degrees

Grant in 2018
720 Degrees Oy, founded in 2012 and headquartered in Helsinki, Finland with an additional location in New York, develops a cloud-based analytics solution for monitoring indoor environmental quality. The company's platform utilizes sensors and related software to collect and evaluate real-time data on various environmental factors such as air quality, thermal comfort, and noise pollution. Key measurements include temperature, humidity, carbon dioxide levels, volatile organic compounds, and particulate matter. 720 Degrees is committed to enhancing health and satisfaction in work environments by providing organizations with actionable insights to optimize workspace conditions, occupational health, job satisfaction, and performance.

Stayble Therapeutics

Grant in 2018
Stayble Therapeutics AB, headquartered in Gothenburg, Sweden, is a clinical-stage pharmaceutical company focused on developing a minimally invasive injection treatment for chronic discogenic low back pain. Their lead product candidate, STA363, is an intradiscally injected formulation designed to alleviate or eliminate pain by addressing the root causes of instability and inflammation within the affected discs. Having completed a Phase 1b clinical trial, STA363 targets patients who have not responded to conventional treatments such as analgesics and physiotherapy, offering a potential alternative to surgery. The company's experienced team comprises a renowned back-pain researcher, seasoned bio-entrepreneurs, and former senior pharmaceutical management, aiming to provide relief to millions of people disabled by chronic low back pain.

Think Outside

Grant in 2018
Think Outside AS is a technology startup based in Bergen, Norway, focused on developing innovative products for the outdoor and hydropower markets. Founded in 2017, the company specializes in manufacturing real-time radar avalanche remote sensing equipment. Its flagship product, Sknow, provides skiers with critical data about snow layers directly beneath their skis, including parameters such as depth, layering, and density. The devices are designed to enhance safety by enabling users to avoid avalanche risk zones and access vital information regarding snow conditions, slope gradients, and applied forces. Through its integrated software solutions, Think Outside aims to improve production planning and reduce health and safety risks in snow-covered environments.

Cellink

Grant in 2018
Cellink AB is a biotechnology company specializing in bioprinting technologies that enable the 3D printing of human organs and tissue models, aimed at applications in pharmaceutical, cosmetic, and medical research. Founded in 2016 and headquartered in Gothenburg, Sweden, with an office in Palo Alto, California, Cellink offers a range of products including bioprinters, imaging systems, dispensing solutions, and bioinks that cater to the needs of researchers and laboratories worldwide. Its product lineup features various bioprinting platforms such as BIO X and BIO X6, along with specialized solutions for skin and cartilage tissue, microfluidics, and single-cell dispensing technologies. Cellink’s bioinks are utilized for diverse applications including drug screening, tissue regeneration, and organoids. The company serves a global customer base that includes universities, hospitals, and public laboratories, and it has established collaborations with organizations like MedImmune and Made In Space, Inc., to further its mission of advancing bioprinting technology in medicine.

Airofit

Grant in 2018
Airofit is a Danish company that has developed a personal training system aimed at strengthening respiratory muscles and improving breathing. Originally designed for medical applications, particularly for patients with lung conditions like asthma and bronchitis, Airofit's equipment focuses on training the diaphragm and intercostal muscles. The system has proven to be effective not only for its initial target demographic but also for athletes seeking to enhance their endurance and respiratory strength. Additionally, singers and musicians who play wind instruments benefit from increased respiratory capacity and coordination, leading to improved tone and sound quality. By providing a means to enhance respiratory performance, Airofit offers a valuable solution for both health and performance enhancement.

Combain

Grant in 2018
Combain is a leading provider of geolocation services for connected IoT devices, specializing in accurate indoor and outdoor positioning. Based in Lund, Sweden, and Palo Alto, USA, the company boasts one of the largest databases in the world, comprising over 88 million cell IDs and 1.3 billion Wi-Fi access points from more than 200 countries. This extensive dataset enables Combain to offer precise positioning services via its cloud-based API, Combain CPS API, and the IoT platform IoTmate.io. The company's customers include prominent mobile network operators, cybersecurity firms, and IoT device manufacturers, all of whom rely on Combain's advanced positioning algorithms to enhance the accuracy and reliability of their location-based services.

Xnovo Technology

Grant in 2018
Xnovo Technology ApS is the commercial result of more than 15 years of Synchrotron and Diffraction-Imaging research at the Technical University of Denmark (DTU). Driven by an urge to make 3D crystallographic X-ray technology accessible for a wider range of materials scientists, Xnovo Technology ApS was founded in December 2012 by Senior Scientist Erik Mejdal Lauridsen, DTU-Energy Conversion, and Professor Henning Friis Poulsen, DTU-Physics.

Tracegrow

Grant in 2018
Tracegrow is a Finnish cleantech company specializing in the circular economy. It has pioneered a unique technology that extracts and purifies vital trace elements, specifically Zinc and Manganese, from alkaline batteries. This innovative process allows the company to create ecological micronutrient products for agriculture, addressing both the global challenge of recycling trace elements and the issue of micronutrient deficiencies in farmland. By utilizing materials from used batteries and metal-containing industrial waste streams, Tracegrow contributes to sustainable farming practices while minimizing the exploitation of the planet's limited resources. The company's focus is on providing environmentally friendly solutions that promote resource reuse and enhance agricultural productivity.

PanCryos

Grant in 2018
PanCryos is a biotechnology company that emerged from the Novo Nordisk Foundation Center for Stem Cell Biology at the University of Copenhagen. It focuses on developing an innovative allogeneic cell therapy, known as PanINSULA, aimed at treating type 1 diabetes. The company's approach leverages novel intellectual property to ensure the safe and efficient large-scale manufacturing of insulin-producing cells. Currently in the pre-clinical stage, PanCryos is prioritizing cost-effective scalability and manufacturing processes to facilitate successful commercialization of its cell therapy. By addressing these challenges early in development, PanCryos seeks to transform diabetes treatment and improve quality of life for patients.

CytaCoat

Grant in 2018
CytaCoat is a private Swedish company based in the Karolinska Institutet Science Park in Solna, Stockholm. Founded by researchers from the Karolinska Institute and the Royal Institute of Technology, the company focuses on developing a proprietary antibacterial coating technology for medical devices. This innovative coating is designed to combat healthcare-associated infections by repelling problematic pathogenic bacteria without the use of antibiotics, thus minimizing the risk of antibiotic resistance. CytaCoat's technology is characterized by its stability under varying pH and ionic conditions, ensuring safety and effectiveness. The company operates a fully equipped laboratory for microbiological evaluation and optimization of its technology, and it has established collaborations with clinical partners such as the Karolinska University Hospital. Additionally, CytaCoat engages with regulatory consultants and clinical research organizations to guide its product development and commercialization efforts.

Colzyx

Grant in 2018
Colzyx AB is a biotechnology company based in Lund, Sweden, founded in 2012, specializing in innovative wound care solutions. The company leverages groundbreaking research from the Medical Faculty at Lund University, focusing on the alpha-3 chain of human collagen VI, which has shown significant wound healing and antimicrobial properties. Colzyx develops bioactive wound dressings that harness these biological mechanisms to enhance the wound healing process while effectively combating a wide range of bacteria, including multidrug-resistant strains. Their products are designed to treat both active and chronic wounds, promoting rapid closure and reducing the risk of infections, thereby improving patient outcomes.

Airmee

Grant in 2018
Airmee is a technology-powered logistics company that provides last-mile delivery services for e-commerce, including same-day and express courier options. Its platform enables real-time route scheduling, delivery tracking, and timing monitoring, and uses machine learning and AI to optimize routing and courier selection, reducing supply-chain friction. The company emphasizes fast, convenient, and environmentally sustainable e-commerce deliveries and is based in Stockholm, Sweden.

Cognibotics

Grant in 2018
Cognibotics AB is a Swedish company based in Lund that specializes in developing methods and services to accurately determine robot properties, including backlash, friction, and non-linear compliance. The company focuses on enhancing the performance and cost-effectiveness of robotic systems by providing solutions that improve the calibration and monitoring of robotic joints. Cognibotics offers techniques that assist in assessing mechanical wear and service requirements, thereby extending the longevity of robotic systems. Its platform aims to deliver high accuracy and predictability, enabling the programming of collaborative robots and supporting innovative applications in motion control and mechanical design. Through its advancements, Cognibotics facilitates businesses in accessing affordable robotic solutions and broadening the scope of their operational capabilities.

Fjolblendir

Grant in 2018
Fjölblendir ehf is a research and development company based in Kópavogur, Iceland, with facilities in Ireland. The company specializes in the invention and development of fuel systems and carburetors utilizing its novel Total Combustion Technology (TCT). This innovative TCT-based fuel system is specifically designed for small off-road engines (SORE), enabling them to comply with EPA phase III regulations without requiring engine modifications or the use of catalysts. Fjölblendir aims to create fuel systems that are not only straightforward to manufacture and calibrate but also generate lower emissions compared to conventional systems.

Asco Harvester

Grant in 2018
Asco Harvester produces a marine mower that mows marine vegetation by the seacoast along with cleaning waste and garbage which increasingly piles up in vulnerable places. Asco is easy to manage and has alot of safety equipment on board. Asco is solid, highly technical and has been modified by innovative developments in recent years. Asco is suitable both for water catchments and in difficult weather conditions at sea thus the Asco reaches different target groups. Asco is designed and constructed from scratch in Iceland. All types of Asco have similar characteristics, therefore most equipment can be used in various Asco types.

Grundium

Grant in 2018
Grundium Ltd, established in 2015 and headquartered in Tampere, Finland, specializes in imaging and multi-camera solutions. The company caters to diverse industries such as transportation, biotechnology, and professional imaging, offering end-to-end solutions that include hardware, software, and user services. Grundium's core expertise lies in providing high-quality, portable digital microscope scanners designed for live telepathology consultations, enabling real-time, high-resolution image transmission between surgeons and pathologists, regardless of location. This innovative technology enhances diagnostic pathology reach and quality while reducing time and costs. Additionally, Grundium provides multi-camera solutions for the transportation industry, capable of withstanding harsh environmental conditions, and offers microscopic imaging platforms for various applications.

TILT Biotherapeutics

Grant in 2018
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

Xzero

Grant in 2018
Xzero is a Swedish company that has spent 20 years in R&D for a new technology for process water in the micro- and nanoelectronics industries. The basic idea is to recycle the water from waste water into Ultrapure Water. The most recent challenge has been to remove nanoparticles in order to make sure these are not spread in the environment and not enter the Ultrapure Water used in cleaning of the nanoelectronics. Third party tests done by The Royal Institute of Technology and Swedish Environmental Research Institute (Sweden), Clarkson University (US), Manta Inc(US) and Anton Paar (Austria) have confirmed that Xzero technology is more efficient than existing technologies in removing nanoparticles from water. In January 2015, Xzero started to industrialize the technology in co-operation with researchers at the Royal Institute of technology in Stockholm, Sweden and at the leading European organization for microelectronics development – imec in Leuven, Belgium. Testing of the first full scale prototype of the industrialized equipment commenced in August 2016 and final industrialized equipment is slotted to be delivered to imec during the first half of 2019. In order to complement the researchers already working on the project, Xzero is recruiting experienced and professional engineers for the industrialization work and experienced sales people for tha marketing. In the commercialization phaseXzero will continue working with imec. Imec has offices in Belgium, the Netherlands, Taiwan, USA, China, India and Japan and a staff of about 2,400 people including several hundred of industrial residents from leading international nanoelectronics companies. Through imec we will be able to reach the largest part of Xzero’s future customers.

Olfactomics

Grant in 2018
Olfactomics is a Finnish university-based spin-off focused on intraoperative tissue assessment to improve breast-conserving surgery. It develops solutions that provide real-time analysis of surgical tissue to help surgeons identify cancer margins and reduce the need for re-operations by enabling more complete tumor removal while preserving healthy tissue. Its instruments use energy-based approaches and analyse the surgical smoke produced during tissue dissection to convey detailed information about the operated tissue, supporting heightened margin awareness and more precise treatment during breast cancer procedures.

Comparo.dk

Grant in 2018
Comparo.dk is an online platform based in Copenhagen, Denmark, that assists users in finding the most affordable car and travel insurance packages. Launched in June 2013, the service simplifies the insurance management process by aggregating data from various family insurance policies. It provides users with a clear overview of their coverage, payment history, and comparisons of different insurance plans. By offering a range of options from multiple insurance providers, Comparo.dk enables users to make informed decisions, choose the best coverage for their needs, and efficiently manage their insurance policies through a single application.

ColdZymes

Grant in 2018
Coldzymes develops enzymes from microorganisms isolated from cold environments from all over the World, e.g. from Greenland, Alaska, Svalbard, Antarctica. Cold-active enzymes from Coldzymes may be used in novel industrial processes that are more - Economic, due to lower consumption of fossil fuel - Efficient, due to increased specific activity of cold-active enzymes - Hygieinic, because food spoilers do not grow at low temperatures Coldzymes’ enzymes are developed in accordance with the Convention on Biological Diversity. Coldzymes is a project under the multi-disciplinary and multi-national initiative Greenland Perspective that brings together researchers, civil society, industry and authorities to explore how Greenland’s human and natural resources can be used to develop new technologies, business opportunities and societal models.

Peerpilot

Grant in 2018
Peerpilot ApS is a Copenhagen-based company that specializes in a performance-based talent assessment platform aimed at enhancing recruitment processes. Established in 2013, Peerpilot's platform facilitates mass screenings and individual candidate assessments through collaborative problem-solving in a virtual environment. Candidates engage in job-specific business challenges, allowing their collaboration, activity, and impact to be evaluated in real-time. This innovative approach enables employers to effectively analyze candidates' team behavior and select individuals best suited for their roles. By leveraging technology and social work data, Peerpilot streamlines the recruitment process, connecting employers with qualified candidates.

Aqua-Q

Grant in 2018
Aqua-Q is a Swedish cleantech company with over 20 years of experience in the water treatment industry. The company specializes in developing and marketing innovative products and processes to ensure safe and clean water for drinking, wastewater treatment, and reuse purposes. Their systems are designed to detect waterborne outbreaks promptly, allowing operators to take immediate action and minimize consequences. Additionally, Aqua-Q provides modular ozone disinfection systems and has patented technologies for killing Legionella bacteria in water systems, point-of-use disinfection, and cold water disinfection with ozone. These solutions are applicable to various industries, including dairy, brewery, and bottled water manufacturing.

Glucostratus

Grant in 2018
Glucostratus Ltd is focused on developing and delivering digital solutions for remote blood glucose monitoring, targeting individuals with diabetes and healthcare professionals. Founded in 2005 and based in Helsinki, Finland, the company enables patients to share their glucose data with healthcare providers via a cloud platform, allowing for improved management of individual health outcomes. Glucostratus’s solutions include a software-as-a-service (SaaS) platform that facilitates easy access for doctors and nurses to patient results, as well as an Internet of Things (IoT) solution tailored for elderly diabetics who may lack technical skills. This comprehensive approach addresses the growing needs of the home care sector, ensuring that both patients and healthcare professionals can effectively monitor and manage diabetes treatment.

Quiske

Grant in 2018
Quiske is a Finnish technology startup developing a Rowing Performance (RowP) system which helps you become a better rower. The RowP System consists of and app and a pod that together can measure, analyze and provide real time feedback on your rowing, so that you can improve and fine tune your technique, which is especially important when rowing in a crew. Its SW automatically sniffs for rowing strokes and produces real time feedback on both boat specific metrics (boat acceleration and velocity) as well as rower specific metrics (oar and seat work of individual rowers).

Tocircle

Grant in 2018
Tocircle is a mechanical technology company established in 2003, focused on developing rotary vane machines inspired by the concepts of Norwegian inventor Kjell Vading. The company has engaged in extensive development and testing, collaborating with major industry players such as Statoil and academic institutions like the Norwegian University of Life Sciences. Tocircle specializes in energy recovery and production, offering a range of machines including pumps, turbines, multiphase expanders, and compressors. These machines are designed to efficiently handle various gas and liquid mixtures while minimizing noise and vibration, thus reducing the need for additional space-consuming equipment. By addressing the growing global demand for environmentally friendly and resource-efficient solutions, Tocircle aims to establish itself as a prominent player in energy efficiency, electricity production, and oil and gas services in Norway. The company partners with the Norwegian research institute IFE and is associated with OREEC and the German industry association B.KWK.

Seafood IQ

Grant in 2018
Seafood IQ is an Icelandic, award-winning Seafood-tech venture that was founded in 2015. They are seafood veterans and P.h.D level technologists that believe, by turning the complex into simple with smart technologies they can create the tools needed to increase trust, comfort, and profit within the seafood value chain. Their team is developing the worlds’ only data platform that combines IoT/RFID, Blockchain, and artificial intelligence to create a new level of trust based on unified digital identities, real-time temperature monitoring and cryptographed background information of every box of fish that is manufactured, transported and then sold into the marketplace.

InDex Pharmaceuticals

Grant in 2018
InDex Pharmaceuticals AB, founded in 2016 and based in Stockholm, Sweden, is a clinical-stage biopharmaceutical company focused on developing innovative treatments for immunological diseases. Its flagship product, cobitolimod, is designed to provide local anti-inflammatory effects, healing mucosa and improving clinical symptoms in patients with ulcerative colitis. The company's platform technology involves DNA-based ImmunoModulatory Sequences (DIMS), which are used to treat a variety of immunological diseases. Additionally, InDex Pharmaceuticals offers DiBiCol, a diagnostic kit that monitors biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy.

Gradientech AB

Grant in 2018
Gradientech AB is a Swedish biotech company that develops microfluidic solutions for studying cell migration and behavior under chemical gradients. Its CellDirector platform enables live imaging and analysis of cells as they respond to defined gradients, with Opal for endothelial migration, angiogenesis, neutrophil and cancer cell migration, and stem cell differentiation, and Ruby for tumor cell and spheroid migration, axon guidance, and differentiation. The company supplies related accessories such as Gradient Marker dyes, Fusion 100 syringe pump, and Vacuum 104 pump to deliver precise fluid flows and maintain gradients. Gradientech serves academic, pharmaceutical, and diagnostic laboratories worldwide and sells products online. It also offers QuickMIC, an antibiotic susceptibility testing system that combines microfluidics with live imaging to assess bacterial responses along a linear antibiotic gradient and provides rapid MIC results for IVD and research use, including positive blood culture samples from sepsis patients. The company emphasizes precise control of the chemotactic environment to enable high-resolution analyses.

GoSleep

Grant in 2018
GoSleep is a Finnish company that specializes in the development and manufacturing of innovative sleeping pods, designed to provide travelers with a private and comfortable resting space in busy airport environments. The GoSleep Pod features a stylish, sleek design that allows it to function as a chair which can be easily converted into a flat bed. It offers a secure storage area for hand luggage beneath the seat and includes power outlets and USB ports for charging electronic devices. The moveable, breathable shade of the pod effectively shields users from airport noise, light, and the gaze of other passengers, creating an ideal environment for rest amid the hustle and bustle of travel.

Memento Payments

Grant in 2018
Memento Ehf is a developer of a cloud-based social payment platform aimed at enhancing the relationship between banks and their customers. Founded in 2014 and based in Reykjavík, Iceland, the company provides a comprehensive software toolkit and mobile payment application that can be seamlessly integrated with existing banking infrastructures. This platform enables banks to launch wallet and peer-to-peer payment services on both iOS and Android devices, facilitating a more engaging and user-friendly banking experience. Memento's vision is to create a Social-to-Bank Relationship Platform, recognizing the importance of technology and regulatory advancements in the financial sector. By focusing on building strong, integrated relationships within consumers' social lives, Memento seeks to empower financial institutions to adapt and thrive in a rapidly evolving fintech landscape.

2cureX

Grant in 2018
2cureX AB operates as a medtech company in Denmark. It is involved in developing IndiTreat, a technology for the treatment of colorectal, ovarian, and kidney cancers. The company was founded in 2006 and is based in Copenhagen, Denmark.

GPX Medical AB

Grant in 2018
Neola Medical AB is focused on advancing neonatal intensive care through its innovative device, NEOLA. This medical technology offers continuous monitoring of lung function and real-time alerts for life-threatening complications in preterm infants. By measuring changes in lung volume and oxygen gas concentration, NEOLA aims to enhance patient care, reduce the duration of intensive care stays, and improve overall health outcomes for vulnerable newborns. The company is rooted in Sweden's rich history of medical technology innovation, which has significantly contributed to advancements in healthcare.

ErkiTónlist

Grant in 2017
ErkiTónlist was founded in 1985 to promote creative endeavours in music, especially those that for one reason or other did not obtain commercial support. ErkiTónlist sf has issued several LPs and CDs with experimental and theatre music, constructed the MIC database for Icelandic music – www.mic.is, produced music videos for experimental music, organized seminars for young musicians – emphasizing on computer music, initiated and organized the biannual ErkiTid – the first electronic music festival in Iceland, supported the development of CALMUS project , a computer program for musical composition, operated a studio for recording, sound design, video production and programming environment for CALMUS, and released CDs with classical as well as contemporary music.

GeoSilica

Grant in 2017
GeoSilica is a company founded in 2012 by Fida Abu Libdeh and Burkni Pálsson, emerging from their research in energy and environmental engineering at the University of Iceland. The company focuses on producing high-purity silica derived from geothermal water at the Hellisheidi Power Plant, in collaboration with ON Energy. GeoSilica employs a unique two-step production process that enhances silica concentration without altering the water's chemical composition, ultimately replacing geothermal water with clean groundwater while maintaining silica levels. The result is a natural liquid silica supplement, introduced in 2014, which is free from additives and chemicals. These supplements are designed to offer health benefits for hair, skin, bones, and muscles, reflecting the company's commitment to utilizing Iceland's volcanic earth resources. GeoSilica continues to expand its product range with ongoing development of new offerings.

SansOx

Grant in 2017
Founded in 2012, SansOx specializes in innovative water purification solutions. It offers modular oxygenation and aeration systems for various applications including drinking water production, fish farming, and industrial water processing. The company aims to enhance potable water systems, wastewater treatment processes, and natural water ecosystems with its low energy consumption solutions.

SAGA Diagnostics

Grant in 2017
SAGA Diagnostics AB is a Swedish company specializing in personalized cancer diagnostics and disease monitoring through molecular genetic analyses, focusing on circulating tumor DNA (ctDNA). Founded in 2016 as a spin-out from a research group at Lund University, SAGA aims to enhance precision cancer medicine and improve patient survival rates with its minimally-invasive liquid biopsy testing services. The company provides a range of services, including gene mutation analysis and treatment monitoring, utilizing advanced technologies such as massively parallel sequencing. SAGA's proprietary tests enable oncologists and biopharmaceutical companies to detect actionable mutations, stratify patient groups, and monitor treatment responses with high sensitivity, thereby contributing significantly to advancements in cancer research and clinical diagnostics.

InfiCure Bio

Grant in 2017
InfiCure Bio is a life science company based in Umeå, Sweden, that specializes in the preclinical development and validation of drugs aimed at chronic inflammatory and fibrotic conditions. Founded in 2015, InfiCure Bio evolved from a project initiated at Umeå Biotech Incubator, led by Prof. Dan Holmberg and Dr. Sofia Mayans. The company has developed a unique preclinical model that simulates fibrosis in multiple organs, such as the liver and kidneys, and is characterized by spontaneous development following chronic inflammation. This model allows for comprehensive testing of anti-inflammatory and anti-fibrotic drugs, offering pharmaceutical companies the ability to evaluate their new therapies through structured studies that include setup, execution, analysis, and reporting of results. InfiCure Bio's focus aligns with addressing significant healthcare challenges associated with conditions like chronic liver disease and chronic kidney disease.

Fisheries Technologies

Grant in 2017
Fisheries Technologies is an Icelandic company specializing in the field of fisheries management on a governmental level. The company's main focus is on data collection procedures and related information systems.

Furhat Robotics

Grant in 2017
Furhat Robotics AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing advanced social robotics platforms. The company designs and manufactures development kits that integrate hardware, software, and APIs, enabling users to create AI interfaces with human-like social intelligence and expressiveness. Furhat's robots can display facial expressions and engage in context-aware interactions, catering to diverse markets such as information services, healthcare, education, and more. With over 70 international business partnerships, the company aims to revolutionize human-machine interactions by mimicking human personality, gestures, and intonation.

Angular Velocity

Grant in 2017
Angular Velocity is a Finnish technology company committed to improving and enriching sports technology with cutting-edge hardware and software solutions.

Rdot Display

Grant in 2017
Rdot Display is a Swedish company focused on transforming the reflective display industry. It specializes in the manufacture of printed displays that are designed to be low power consuming and efficient, catering to small display needs. Rdot's products are environmentally friendly and cost-effective, making them suitable for a variety of applications, including sensors, packaging, disposables, electronic shelf labels, and various consumer electronics. By enabling users to display simple messages with minimal power consumption and cost, Rdot Display aims to provide innovative solutions that meet contemporary demands for sustainability and efficiency.

Radisurf

Grant in 2017
RadiSurf ApS specializes in providing advanced adhesion solutions for a variety of industries, including healthcare, automotive, offshore, nutrition, and electronics. Founded in 2015 and located in Risskov, Denmark, the company develops a range of products designed to facilitate bonding between metal and plastic materials. Its key offerings include the RadiBond adhesion system, a chemical coating for thermoplastics and thermo sets, and RadiPrime Metal-Epoxy Primer Systems that create stable bonds between metals and epoxies. RadiSurf's technology also encompasses nano-coatings that enable adhesion for diverse surfaces, such as metal, glass, and carbon, while addressing challenges in welding and over-moulding processes. The company's innovative solutions support applications in sustainable energy production and storage, enhancing the performance and durability of hybrid materials.

Ilya Pharma

Grant in 2017
Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in developing biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients.

AddiFab

Grant in 2017
AddiFab is a Danish company specializing in advanced additive manufacturing solutions, particularly focused on 3D printing technology. The company has developed proprietary 3D printer systems and specialized print resins, enabling manufacturers to create precise and repeatable molds for low-volume injection molding. This innovative approach allows for the production of complex parts quickly and cost-effectively, while also reducing environmental impact compared to traditional methods. AddiFab's technology enables manufacturers to produce unique items, prototypes, and spare parts using a wide range of materials, from soft rubbers to hard metals, all on a single platform. With operations in Denmark and a presence in Palo Alto, California, AddiFab is led by a team of experienced professionals committed to transforming the injection molding industry.

DACON AS

Grant in 2017
Dacon was established in 1979 and is a leading supplier of safety, rescue, and inspection equipment for professional use. Dacon is a manufacturer, importer, and distributor, with daughter companies offering inspection services in Norway and Thailand, inspection equipment in The Netherlands as well as protective equipment cases/foam converting in Norway.

Spectral Engines

Grant in 2017
Founded in 2014, Spectral Engines develops and manufactures miniaturized spectral sensors for various applications. These include moisture measurement in pharmaceutical powders, food composition analysis (protein, fat, sugars), gas detection, and process spectroscopy.

Optomed

Grant in 2017
Optomed is a Finnish medical technology company specializing in retinal imaging devices and solutions. It develops, manufactures, and markets handheld fundus cameras globally for screening eye diseases like diabetic retinopathy, glaucoma, and AMD.

SagaMedica

Grant in 2017
SagaMedica, established in 2000, is an Icelandic company specializing in the manufacture of natural products derived from medicinal herbs. The company's supplements are formulated using herbs that have been traditionally used for over a millennium by Icelanders. SagaMedica sources its ingredients from Iceland’s pristine environment and employs eco-friendly harvesting methods to ensure sustainability. With a strong academic foundation, the company focuses on producing herbal remedies with proven efficacy for common health issues such as sore throats, memory support, urinary frequency, and overall vitality.

Offshore Kinetics

Grant in 2017
Offshore Kinetics is an innovative Norwegian small and medium-sized enterprise (SME) operating in the offshore wind sector. The company develops advanced offshore wind turbine support structures that leverage proven technology and extensive experience in the offshore oil and gas industry. This approach aims to enhance safety during the production and operational phases of offshore wind farms while addressing key technological challenges in wind energy. Offshore Kinetics’ cost-efficient designs significantly reduce both capital and operational expenditures, positioning the company as a competitive player in the evolving offshore wind market.

Zemission AB

Grant in 2017
Zemission AB specializes in innovative energy production solutions. Based in Lund, Sweden, the company is renowned for its patented non-monolith technology enabling catalytic combustion of liquid fuels at zero emission operation. This technology powers various applications such as catalytic vehicle heaters and absorption refrigerators.

Alelion Energy Systems

Grant in 2017
Alelion Energy Systems AB, based in Nödinge, Sweden, specializes in energy storage solutions and the development of high-performance lithium-ion batteries. Established in 2006 as a spin-out from ETC Batteries and Fuelcells, the company focuses on designing and delivering tailor-made battery systems and power electronics that cater to demanding applications across various industries. Alelion Energy Systems emphasizes the safety and longevity of its lithium-ion cells, which are engineered to offer exceptional cycle performance. The company manages the complete battery subsystem, allowing clients to concentrate on their core products and applications. With a production area of 1600 m² and a team of highly educated employees possessing extensive experience in electronics, software, and mechanical development, Alelion combines robust technical expertise with a commitment to efficient production processes. The company's evolution included a change of ownership in 2007 and a rebranding in 2016, highlighting its continuous growth and innovation in the energy storage sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.